5 completed, 1 not yet recruiting. 6 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 5, Not yet recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Familial Hypercholesterolemia: new trials by email Literature Review of Familial Hypercholesterolemia trials Research Report on Familial Hypercholesterolemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A VSA003 Phase 1 Study in Chinese Adult Healthy Volunteers VSA003, 0.9% NaCl - Dyslipidemias, Familial Hypercholesterolemia | Phase 1 | Completed | Visirna Therapeutics HK Limited | 36 | 2023-06-01 | 2025-09-12 |
| Exosome-based Nanoplatform for Ldlr mRNA Delivery in FH Low Density Lipoprotein Receptor mRNA Exosomes - Familial Hypercholesterolemia | Phase 1 | Not yet recruiting | Tang-Du Hospital | 30 | 2021-12-01 | 2021-09-14 |
| Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients ARO-ANG3, sterile normal saline (0.9% NaCl) - Dyslipidemias, Familial Hypercholesterolemia | Phase 1 | Completed | Arrowhead Pharmaceuticals | 93 | 2019-01-07 | 2025-12-24 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS ANGPTL3-LRx in Healthy Volunteers With Elevated Triglycerides and Participants With Familial Hypercholesterolemia IONIS ANGPTL3-LRx, Placebo - Hypertriglyceridemia, Familial Hypercholesterolemia | Phase 1 | Completed | Ionis Pharmaceuticals, Inc. | 48 | 2015-11-30 | 2020-11-19 |
| Efficacy of a New Symbiotic Formulation in Children With Familial Hypercholesterolemia Lactobacillus paracasei B21060, low satured diet - Dyslipidemia, Familial Hypercholesterolemia | Phase 1 / Phase 2 | Completed | Federico II University | 40 | 2012-01-01 | 2014-01-29 |
| Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia gene therapy - Familial Hypercholesterolemia | Phase 1 | Completed | National Center for Research Resources (NCRR) | 5 | 1992-06-01 | 2005-06-24 |
Hyperlipoproteinemia Type II (6) · Dyslipidemias (3) · Hypertriglyceridemia (3) · Metabolism, Inborn Errors (1) · Rare Diseases (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (6) · Genetic Diseases, Inborn (6) · Hyperlipidemias (6) · Hyperlipoproteinemias (6) · Lipid Metabolism Disorders (6) · Lipid Metabolism, Inborn Errors (6) · Metabolic Diseases (6) · Nutritional and Metabolic Diseases (6) · Metabolism, Inborn Errors (5) · Dyslipidemias (3) · Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Genetic Therapy (1) · IONIS-ANGPTL3-LRx (1) · Saline Solution (1)
Arrowhead Pharmaceuticals (1) · Federico II University (1) · Ionis Pharmaceuticals, Inc. (1) · National Center for Research Resources (NCRR) (1) · Tang-Du Hospital (1) · Visirna Therapeutics HK Limited (1)
China (2) · Australia (1) · Canada (1) · New Zealand (1)
James M. Wilson (1) · Lijun Yuan (1)
PMID 28538111, PMID 33900278, PMID 37626170, PMID 41946917
2015 (1)